Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk
Clinical medicine. Cardiology · 2009
DOI: 10.4137/cmc.s2111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical medicine. Cardiology, 2009. Verfasst von Lawrence F Bielak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Michigan, Ann Arbor, Michigan. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCRR NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Bone-marrow derived progenitor cells (PCs) may play a role in maintaining vascular health by actively repairing damaged endothelium. The purpose of this study in asymptomatic Old Order Amish men (n = 90) without hypertension or diabetes was to determine if PC count, as determined by CD34+ cell count in peripheral blood, was associated with 10-year risk of cardiovascular disease (CVD) and measures of subclinical atherosclerosis. Methods and Results CD34+ cell count by fluorescence-activated cell sorting, coronary artery calcification (CAC) by electron beam computed tomography, and CVD risk factors were obtained. Carotid intimal-medial thickness (CIMT) also was obtained in a subset of 57 men. After adjusting for 10-year CVD risk, CD34+ cell count was significantly associated with CAC quantity ( p =0.03) and CIMT ( p < 0.0001). A 1-unit increase in natural-log transformed CD34+ cell count was associated with an estimated 55.2% decrease (95% CI: −77.8% to −9.3%) in CAC quantity and an estimated 14.3% decrease (95% CI: −20.1% to −8.1%) in CIMT.
Conclusions
Increased CD34+ cell count was associated with a decrease in extent of subclinical atherosclerosis in multiple arterial beds, independent of 10-year CVD risk. Further investigations of associations of CD34+ cell count with subclinical atherosclerosis in asymptomatic individuals could provide mechanistic insights into the atherosclerotic process.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan.
Förderung
- NIDDK NIH HHS
- NCRR NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Bielak, L. F., Horenstein, R. B., Ryan, K. A., Sheedy, P. F., Rumberger, J. A., Tanner, K., Post, W., Mitchell, B. D., Shuldiner, A. R., & Peyser, P. A. (2009). Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk. Clinical medicine. Cardiology. https://doi.org/10.4137/cmc.s2111
Vancouver
Bielak LF, Horenstein RB, Ryan KA, Sheedy PF, Rumberger JA, Tanner K, et al. Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk. Clinical medicine. Cardiology. 2009. doi:10.4137/cmc.s2111
BibTeX
@article{Bielak2009,
author = {Bielak, Lawrence F and Horenstein, Richard B and Ryan, Kathleen A and Sheedy, Patrick F and Rumberger, John A and Tanner, Keith and Post, Wendy and Mitchell, Braxton D and Shuldiner, Alan R and Peyser, Patricia A},
title = {Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk},
journal = {Clinical medicine. Cardiology},
year = {2009},
doi = {10.4137/cmc.s2111}
}
EUVIMED